Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Taminco, known as "The Amine Company," is a leading global producer of alkylamines and their derivatives, which serve as essential building blocks in the pharmaceutical, agrochemical, and personal care industries. The company specializes in the production of methylamines and higher alkylamines, providing critical intermediates for the synthesis of various active pharmaceutical ingredients. Following its acquisition by Eastman Chemical Company in 2014, Taminco's operations were integrated into Eastman's specialty chemicals segments. Their portfolio includes products for water treatment, animal nutrition, and crop protection, alongside their significant contributions to the healthcare supply chain. The company maintains a strong global presence with manufacturing facilities across Europe, North America, and Asia.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Taminco.